BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Osseon Therapeutics, Inc. Announces CE Mark Approval for New Vertebral Augmentation Device - the Osseoflex® SB (Steerable Balloon)


2/23/2012 7:26:11 AM

SANTA ROSA, Calif., Feb. 22, 2012 /PRNewswire/ -- Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex® SB (steerable balloon), received CE Mark approval for commercial release in the European Union. Osseoflex SB's innovative technology represents a game changing development for the treatment of vertebral compression fractures (VCFs). Employing a unipedicular approach, the steerable Osseoflex SB can navigate with unprecedented precision, accuracy, and control within the vertebra to create a central cavity across the sagittal midline or in other specific areas within the vertebral body. This minimally invasive, single-point-access reduces procedure time and decreases risk to the patient compared to systems requiring multiple access points.

CE Mark approval for Osseoflex SB permits surgeons and other physicians throughout Europe to use Osseoflex SB for the treatment of symptomatic spinal fractures. Numerous countries in other regions, including Asia, South America, and the Middle East also accept CE Mark approval as proof of clinical suitability, allowing Osseon's innovative technology to be used in markets comprising more than one billion people.

Osseon's medical device systems employ proprietary steerable devices to correct fractures of the spinal vertebrae, using a procedure called Osseoplasty®. Hundreds of thousands of patients suffer from VCFs in the U.S. and Europe annually due to osteoporosis, acute trauma, or degenerative bone and joint disease. "The capability to access the entire vertebra through a single point of access reduces procedure time and decreases pain and risk to the patient compared to current systems requiring multiple access points. These are significant clinical enhancements over existing kyphoplasty systems," said John Stalcup, Ph.D., CEO of Osseon.

About Osseon

Osseon® Therapeutics, Inc. focuses on bringing to market alternative minimally invasive treatments for degenerative bone and joint disease. Headquartered in Santa Rosa, CA, the company's innovative technology and delivery system provides comparable or better efficacy and safety than other commercial solutions, while offering significant advantages in efficiency and cost. By improving the treatment of compression fractures within the lower portion of the thoracic and the entire lumbar vertebral spine, Osseon offers alternative solutions to patients, as well as the physicians and medical facilities that treat them. Its products have received both FDA clearance and the CE Mark for product distribution in the United States and the European Union.

Osseon® is a registered trademark of Osseon Therapeutics, Inc.

For more information, visit our web site at www.osseon.com



Read at BioSpace.com
Read at News-Medical

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES